Form 8-K · Current report
Ameren 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0001002910
- Accession no.
- 0001104659-26-090493
Summary
Ameren delivered a notice under its Equity Distribution Sales Agreement increasing the authorized aggregate gross sales price under its equity distribution program by $2 billion, leaving up to $2.2667 billion of common stock available for issuance.
Key points
- On July 31, 2026, Ameren delivered a notice under Section 3(x) of its Equity Distribution Sales Agreement.
- The notice increased the aggregate gross sales price authorized under Ameren's equity distribution program by $2,000,000,000.
- After the increase, common stock with an aggregate gross sales price of up to $2,266,700,000 remains available for issuance under the program.
- Ameren has no obligation to offer or sell common stock under the agreement and may suspend offers at any time.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
ITEM 8.01 Other Events. On July 31, 2026, Ameren Corporation (the “Company”) delivered a notice pursuant to Section 3(x) of its Equity Distribution Sales Agreement dated May 12, 2021, as amended and supplemented, including by the First Amendment to Equity Distribution Sales Agreement dated August 7, 2025 (as so amended and supplemented, the “Sales Agreement”), with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.